GLP-1 RAs share multiple mechanisms of action, including improvement of insulin secretion in response to hyperglycemia, suppression of glucagon hypersecretion, deceleration of gastric emptying reducing post-meal glycemic excursions, and changes in appetite and satiety leading to a reduction in body weight [1–4]. This evidence concerns the gene GCG and Hyperglycemia.